GUJARAT THEMIS BIOSYN LTD.

Scale -

Ebitda is 77.96 Rs Cr; in Top Quartile
PBT is 15.17 Rs Cr; in Top Quartile
PAT is 46.68 Rs Cr; in Top Quartile; Continuous Decline over 3 years
Quarterly Ebitda is 20.79 Rs Cr; in Top Quartile
Quarterly Profit is 11.07 Rs Cr; in Top Quartile

Profitability -

PBDIT Margin is 47.01 %; in Top Quartile; Continuous Decline over 3 years
PAT Margin is 28.15 %; in Top Quartile; Annual Decline is -13 %; Continuous Decline over 3 years
Quarterly Ebitda Margin is 47 %; in Top Quartile
Quarterly Profit margin is 25 %; in Top Quartile

Return -

ROA is 9.27 %; in Top Quartile; Annual Decline is -43 %; Continuous Decline over 3 years; 5 Year CAGR is -29 %
ROE is 16.22 %; in Top Quartile; Continuous Decline over 3 years; 5 Year CAGR is -21 %

ROCE is 15.32 %; Annual Decline is -35 %; Continuous Decline over 3 years; 5 Year CAGR is -28 %
Asset Turnover is 41 %; Annual Decline is -29 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -22 %

Efficiency -

Inventory Turnover Ratio is 16.2; in Top Quartile; 5 Year CAGR is 60 %; Annual Decline is -55 %
Operating cash flow is 48.78 Rs Cr; in Top Quartile; Annual Decline is -46 %

Current Ratio is 1.12; Annual Decline is -56 %; Continuous Decline over 3 years; 5 Year CAGR is -30 %
Quick Ratio is 0.93; Annual Decline is -59 %; Continuous Decline over 3 years; 5 Year CAGR is -30 %

Solvancy -

Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %; Continuous Decline over 3 years

Debt/Equity is 0.56; Annual Growth is 367 %; Continuous Growth over 3 years
Long term Debt is 128 Rs Cr; Annual Growth is 332 %; Continuous Growth over 3 years; in Top Quartile
Total Debt is 160 Rs Cr; Annual Growth is 435 %; Continuous Growth over 3 years; in Top Quartile

Quality -

Change in Inventories/Total Expenses is -9 %; Annual Decline is -487 %; Continuous Decline over 3 years; in Bottom Quartile
Operating cashflow/PAT is 104 %; in Top Quartile; Annual Decline is -44 %

Operating cashflow/ebitda is 63 %; Annual Decline is -51 %
Exceptional Items/PBT is 0 %; in Top Quartile
Other Expenses/Total Expenses is 49 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search:

Gujarat Themis Biosyn Q2FY27 Results: Investor meet set for Nov 5

Past/current

Gujarat Themis Biosyn GUJTHEM Credit Rating Filing Withdrawn

Past/current

Gujarat Themis Biosyn Share Price: price fall and valuation

Past/current

Gujarat Themis Biosyn (NSE:GUJTHEM): What Does the Q2 FY27 Depository Compliance Certificate Mean?

Past/current

CAM acts as counsel to EAAA India Alternatives Ltd. and Avendus Finance Pvt. Ltd. in connection with a secured financing of INR 585 crores raised by Gujarat Themis Biosyn Ltd.

Past/current

SEBI permits Gujarat Themis Biosyn foreign QIB QIP, widening investor pool

Past/current

Gujarat Themis Biosyn GUJTHEM 45th AGM Voting Results

Past/current